Ran et al. showed that SCD1 expression was required for the epithelial-mesenchyme transition associated with in vivo metastasis and found that elevated SCD1 tumor expression was a robust negative clinical prognostic in colorectal carcinoma [161]. The gene discussed is SCD; the disease is neoplasm.